Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment: antiestrogens

Canada

• Cancer Care Ontario
  • Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations [2008]

United Kingdom

• National Institute for Health and Clinical Excellence
  • Breast cancer (metastatic) - fulvestrant [2011]

United States of America

• National Guideline Clearinghouse
  • Fulvestrant for systemic therapy of locally advanced or metastatic breast cancer in postmenopausal women: guideline recommendations. Program in Evidence-based Care [2008]

Articles in journals

• Cancer Research
  • Nuclear p21-Activated Kinase 1 in Breast Cancer Packs Off Tamoxifen Sensitivity [2006]

• Clinical Cancer Research
  • Clinical Implications of CYP2D6 Genotyping in Tamoxifen Treatment for Breast Cancer [2009]

• Endocrine-Related Cancer
  • Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implications [2007]
  • Pure oestrogen antagonists for the treatment of advanced breast cancer [2006]
  • Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA [2006]
  • Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience [2005]
  • Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer [2005]
  • Mechanisms of tamoxifen resistance [2004]

• Journal of the National Cancer Institute
  • Is tamoxifen the Rosetta stone for breast cancer? [2003]
  • Is low-dose tamoxifen useful for the treatment and prevention of breast cancer? [2003]

{Related topics}

• Guidelines
  • Breast cancer treatment